Release date: 23 May 2019
Promoter – Financial Intermediary
LABORATORIOS HIPRA SALocation
Description
The project consists of research and development (R&D) investments and other expenditures related to animal health.
Objectives
The EIB loan will be used to support the implementation of the company's strategy. The investments are expected to support the promoter's competitiveness and growth.
Sector(s)
- Industry - Manufacturing
Proposed EIB finance (Approximate amount)
EUR 35 million
Total cost (Approximate amount)
EUR 82 million
Environmental aspects
The project concerns investments in research, development, and technology deployment that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during the appraisal.
Procurement
The promoter has been assessed by the EIB as being a private company not operating in the utilities sector and not having a status of a contracting entity, thus not being subject to EU rules on public procurement.
Status
Signed - 28/05/2019
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).